Cargando…
Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
OBJECTIVE: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epitheli...
Autores principales: | Hayashi, Yusuke, Toshida, Hiroshi, Matsuzaki, Yusuke, Matsui, Asaki, Ohta, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872273/ https://www.ncbi.nlm.nih.gov/pubmed/27257394 http://dx.doi.org/10.2147/IMCRJ.S103299 |
Ejemplares similares
-
Visual outcome after emergency surgery for open globe eye injury in Japan
por: Toride, Ai, et al.
Publicado: (2016) -
Prevalence of drug resistance and culture-positive rate among microorganisms isolated from patients with ocular infections over a 4-year period
por: Shimizu, Yusuke, et al.
Publicado: (2013) -
Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018) -
A Case of Atypical Mucin Balls Wearing Extended Wear of Silicone Hydrogel Lens for Therapeutic Use
por: Matsuzaki, Yusuke, et al.
Publicado: (2013) -
Preoperative and Postoperative Optical Coherence Tomography Findings in Patients with Rhegmatogenous Retinal Detachment Involving the Macular Region
por: Matsui, Asaki, et al.
Publicado: (2013)